Kjetil Taskén

25PUBLICATIONS
128CO-AUTHORS
Cancer geneticsCancer diagnosisMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 04, 2026
Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025.

Elisa Bjørgo, Nina Ånensen, Gro Live Fagereng

|Feb 24, 2026
'Crossing borders' in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine.

Maria Martin Agudo, Henk Van der Pol, Gabriel Bratseth Stav

|Feb 19, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology.

Oskar Frisell, Eline Aas, Pia Sofie Henkel

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Jan 22, 2026
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity.

Elise Solli, Alessio Bevilacqua, Mathias Wenes

|Jan 07, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

Pageof 5

Frequent Collaborators

9 joint publications

Sigrid S Skånland

4 joint publications

Gro Live Fagereng

4 joint publications

Åslaug Helland

2 joint publications

Tina Kringelbach